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symptom onset, increased during the 
symptomatic  period  (as  shown  by 
higher titers on day 10), peaked by day 
30 (2 weeks after recovery), then de-
clined slowly over several years. Zaire 
ebolavirus  IgG  remained  detectable, 
often at high levels, >11 years after 
the infection.
These long-lasting IgG antibody 
responses found in 20 survivors of 3 
different  Zaire  ebolavirus  outbreaks 
rule out the hypothesis that low Ebola 
virus (and Marburg virus) seropreva-
lence rates found in epidemic regions 
of Africa are due to rapid loss of spe-
cific  IgG. Whether  this  immunity  is 
sufficient to protect from recurrent in-
fection remains undetermined. These 
findings show that IgG ELISA is suit-
able for epidemiologic and epizootio-
logic investigations of Ebola and that 
Zaire ebolavirus IgG is an excellent 
indicator of Zaire ebolavirus circula-
tion in humans.
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Varibaculum  
cambriense  
Infections in Hong 
Kong, China, 2006 
To the Editor: Varibaculum cam-
briense  is  an  anaerobic,  gram-posi-
tive,  diphtheroid  bacterium  that  was 
described by Hall et al. in 2003 (1). 
Biochemical  testing,  electrophoretic 
analysis  of  whole-cell  proteins,  and 
phylogenetic  analysis  of  16S  rRNA 
gene sequences showed that V. cam-
briense is related to but distinct from 
Actinomyces  spp.  and  related  taxa, 
including the genera Actinobaculum, 
Arcanobacterium, and Mobiluncus.
Although  its  natural  habitat  re-
mains  unknown,  V.  cambriense  has 
been  isolated  from  intrauterine  de-
vices and human vagina and abscess 
specimens (2). Commercial systems, 
such as analytical profile index (API) 
Rapid  ID  32  Strep  and  Coryne  kits 
(bioMérieux, Marcy l’Etoile, France), 
used in differentiation of novel bacte-
ria provide biochemical profiles useful 
for identification of V. cambriense (1). 
However, the absence of data on this 
organism in manufacturers’ databases 
has hampered recognition of V. cam-
briense in routine clinical laboratories. 
We report 4 cases of V. cambriense in-
fection and show that this bacterium is 
a potential pathogen in skin and soft 
tissue infections.
In  2006,  four  isolates  of  gram-
positive  curved  bacilli  that  grew  on 
Columbia agar with 5% horse blood 
under  anaerobic  conditions  were  re-
ferred by 2 regional hospitals in Hong 
Kong to our laboratory for identifica-
tion.  These  isolates  originated  from 
the abscess specimens of 4 patients.
Patient 1 was a 45-year-old wom-
an with a right ovarian chocolate cyst 
and endometriosis who had undergone 
laparotomy, right salpingo-oophorec-
tomy, and lysis of adhesions in 2001. 
Since then, she had a recurrent abscess 
over the umbilical scar that was treat-
ed conservatively. Culture of pus from 
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the umbilical scar grew an unidenti-
fied  gram-positive  bacillus  (M124). 
Histologic analysis of umbilical tissue 
showed acute suppurative inflamma-
tory cells and microabscess formation. 
The  patient  refused  follow-up  and 
no antimicrobial drug treatment was 
given.
Patient 2 was a 25-year-old man 
who had a history of excision of mul-
tiple sebaceous cysts in the groin, and 
buttock pain and swelling for 4 days. 
He had no previous trauma and was 
afebrile. An abscess was incised and 
drained.  Culture  of  tissue  obtained 
grew an unidentified gram-positive ba-
cillus (M397) and a Peptostreptococ-
cus spp. The infection later subsided 
without antimicrobial drug treatment.
Patient 3 was a 34-year-old man 
with a lump in the left groin that had 
been present for 1 year. He was hos-
pitalized with erythema and increased 
swelling of the lesion. An abscess was 
diagnosed, incised, and drained. Gram 
staining  of  pus  showed  numerous 
leukocytes and gram-positive bacilli. 
Culture yielded an unidentified gram-
positive  bacillus  (M380).  He  was 
treated with ampicillin and cloxacillin, 
and the wound healed.
Patient 4 was a 55-year-old wom-
an with an abscess on her back. She 
had a 3-year history of seronegative 
rheumatoid  arthritis  but  was  not  re-
ceiving  immunosuppressant  therapy. 
The  abscess  was  drained,  and  gram 
staining of pus showed numerous leu-
kocytes and gram-positive cocci and 
bacilli. Culture yielded Peptostrepto-
coccus spp. and an unidentified gram-
positive bacillus (M398). The abscess 
healed  without  antimicrobial  drug 
treatment.
The 4 unidentified gram-positive 
bacilli  from  these  patients  were  ini-
tially characterized by using the API 
Rapid ID 32 Strep and Coryne kits. 
Doubtful  identifications  at  various 
confidence  levels  were  obtained,  in-
cluding Corynebacterium diphtheriae 
var.  mitis  or  var.  belfanti,  Gardner-
ella  vaginalis,  Streptococcus  mitis, 
S.  oralis,  Gemella  morbillorum,  and 
Aerococcus urinae. Sequencing of full 
length 16S rRNA genes suggested that 
the isolates were V. cambriense; Gen-
Bank  BLAST  (http://blast.ncbi.nlm.
nih.gov/Blast.cgi)  results  showed  V. 
cambriense type strain CCUG 44998T 
sequence as the best match (identities 
98%–99%) (3).
Biochemical  reactions  of  the 
strains were similar to those of CCUG 
44998T (1). All 4 isolates grew poorly 
in air and 5% CO2, were catalase nega-
tive, did not hydrolyse esculin or gela-
tin, or reduce nitrates. The 4 isolates 
did  not  ferment  most  of  the  carbo-
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Table. Characteristics and test results for 4 isolates of unknown bacteria, Hong Kong, China, 2006* 
Isolate  
Characteristic 
Varibaculum 
cambriense type 
strain CCUG 44998
T M124  M397  M380   M398 
Hospital    B  B  A  A 
Patient sex/age, y    F/45  M/25  M/34  F/55 
Date referred/isolated    2006 May   2006 Dec  2006 Dec  2006 Dec 
API test code           
  Rapid ID32 Strep    00100010100  00102010100  02122001100  00002011100 
  Coryne    1010321  1410321  1010721  1010321 
Acid production from           
  Glucose  +  +  +  +  + 
  Lactose  –  –  –  –  – 
  Maltose  V  – (+)  – (+)   +  + 
  Melibiose  –  –  –  –  – 
  Pullulan  –  –  –  –  – 
  Raffinose  –  –  –  –  – 
  Ribose  V  +  +  +  – (+) 
  Sucrose  V  +  +  +  + 
  Trehalose  V  –  –  +  – 
  MBDG  –  –  –  –  – 
Hydrolysis of hippurate  V  +  +  –  + 
Production of           
Į-galactosidase  –  –  –  +  – 
ȕ-galactosidase  V  –  – (+)  –  – 
Į-glucosidase  +  – (+)  – (+)  – (+)  – (+) 
  Alkaline phosphatase  –  –  –  –  – 
  APPA  V  –  +  +  + 
GenBank accession no.†    FJ169866  FJ169867  FJ169868  FJ169869 
Identity to type strain CCUG 44998
T, %    99  98  99  99 
*API, analytical profile index; V, variable; MBDG, methyl-ȕ-D-glucopyranoside; APPA, alanyl-phenylalanyl-proline arylamidase. Test 
results were obtained by using the API Rapid ID32 Strep kit (bioMérieux, Marcy l’Etoile, France). Results in parentheses were obtained 
by using the API Coryne kit (bioMérieux). 
†For 16S rRNA gene sequence. LETTERS
hydrates in the 2 API kits, except for 
ribose, maltose, glucose, and sucrose. 
Discrepancies in results between the 2 
test kits were seen with ribose in 1 iso-
late (M398) and maltose in 2 isolates 
(M124 and M397). One isolate (M380) 
did not hydrolyze hippurate but pro-
duced acid from trehalose and xylose. 
This isolate was also α-galactosidase 
positive,  a  result  different  from  that 
of the type strain. All 4 isolates were 
α-glucosidase positive and 3 were ala-
nyl-phenyl-alanyl-proline arylamidase 
positive. Some of the biochemical re-
actions  for  the  4  isolates,  including 
all tests for delineating V. cambriense 
from  other  catalase-negative  Actino-
myces spp. (1), are summarized in the 
Table.
We report the isolation of V. cam-
briense from 4 patients with purulent 
skin  and  soft  tissue  infections.  Our 
findings  contribute  to  understanding 
of  the  clinical  and  pathogenic  po-
tential  of  this  anaerobic  bacterium. 
Gram-positive diphtheroid organisms 
from wound specimens are occasion-
ally considered to be skin commensal 
organisms.  Clinical  microbiologists 
should be aware of this organism and 
the current inadequacy of commercial 
systems for its identification. We have 
shown that 16S rRNA gene sequenc-
ing is a useful alternative to gas–liquid 
chromatographic analyses of cell wall 
fatty acids or metabolic products for 
identification of anaerobic gram-pos-
itive bacilli.
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Outbreaks of  
Hemotrophic  
Mycoplasma  
Infections in China
To the Editor: Infections caused 
by  hemotrophic  mycoplasmas  (for-
merly  called  eperythrozoonoses)  in 
animals and humans have been emerg-
ing in the People’s Republic of China 
in recent years. To date, 6 hemotrophic 
Mycoplasma spp. have been identified 
in rodents and mammals (1). M. suis 
from  pigs,  M.  wenyonii  from  cattle, 
and M. ovis from sheep have been con-
firmed;  the  human  pathogen,  which 
is most frequently observed in China, 
has not been genetically identified (2). 
However, the zoonotic potential of the 
bacteria is evident because the disease 
is more prevalent in farmers and veter-
inary doctors, who have frequent close 
contact  with  domestic  animals,  than 
in  other  persons  (2).  Vertical  trans-
mission from mother to fetus has also 
been confirmed (2). In animals, espe-
cially in piglets, the disease is charac-
terized by febrile acute anemia, jaun-
dice, and eventual death resulting from 
concurrent  infection  with  other  mi-
crobes (3–6). Infected humans may be   
asymptomatic or have various clinical 
signs,  including  acute  fever,  anemia, 
and severe hemolytic jaundice, espe-
cially  in  infected  neonates.  Pregnant 
women and newborns were reported to 
be more vulnerable to the disease than 
others and to show more severe clini-
cal signs after infection (2).
We  conducted  an  epidemiologic 
investigation  of  hemotrophic  myco-
plasma infections in China by review-
ing all reported cases and outbreaks 
for 1994–2007. Clinical cases for >6 
animal species (including pigs, cows, 
goats, horses, foxes, chickens, and hu-
mans) were reported during the period 
(Table). The number of reported cases 
varied from year to year. Human infec-
tions were confirmed by clinical and 
laboratory methods (2). We reinvesti-
gated blood samples of >600 pigs with 
previous diagnoses of mycoplasma in-
fection accompanied by clinical signs 
of  fever  and  jaundice.  Slides  were 
made and stained in Giemsa-staining 
solution. We used light microscopy to 
look for the presence of M. suis on the 
erythrocyte surface. We also used flu-
orescence microscopy to look for the 
microbes by mixing a drop of infected 
blood  with  acridine  orange  solution 
(0.1 mg/mL). The microbes bound to 
red blood cells were examined with a 
confocal  microscope.  Positive  cases 
were  further  confirmed  by  PCR  us-
ing primers of the small subunit RNA 
gene  sequences.  All  samples  were 
PCR positive, but PCR sensitivity is 
higher than sensitivity of acridine or-
ange  staining,  which  is  higher  than 
sensitivity of Geimsa staining.
Hemotrophic  mycoplasma  infec-
tion is still a neglected zoonotic disease, 
which poses a threat to public health 
and the animal industry, especially in 
China (2,7). The prevalence of the dis-
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